[1]
R. Silva, “A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal”, Acta Med Port, vol. 30, no. 6, pp. 449–456, Jun. 2017.